ARTICLE | Company News
Amgen, ZymoGenetics Inc deal
May 24, 2004 7:00 AM UTC
ZGEN granted AMGN exclusive worldwide rights for patents covering a metabolic disease target. In exchange, AMGN will purchase $10 million of ZGEN stock and pay an upfront license fee. ZGEN is eligible...